Home
>
US Stocks
>
Seelos Therapeutics Inc
Seelos Therapeutics Inc
SEEL

Seelos Therapeutics Inc (SEEL)

$2.237.21%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
2.2
Today Low/High
2.2 / 2.3
52 Week Low/High
$0.56 / $6.6
Market Cap
$202.58M

Company Details

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases. The Company's robust portfolio includes several late-stage clinical assets targeting indications including Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD), amyotrophic lateral sclerosis (ALS), Sanfilippo syndrome, Parkinson's Disease, other psychiatric and movement disorders plus orphan diseases.
Organisation
Seelos Therapeutics Inc
Headquaters
New York, New York, US
Employees
10
Industry
Pharmaceuticals: Other
CEO
Raj Mehra

Discover more

Frequently Asked Questions

What is Seelos Therapeutics Inc (SEEL) share price today?

Can Indians buy Seelos Therapeutics Inc (SEEL) shares?

How can I buy Seelos Therapeutics Inc (SEEL) shares from India?

Can Fractional shares of Seelos Therapeutics Inc (SEEL) be purchased?

What are the documents required to start investing in Seelos Therapeutics Inc (SEEL) stocks?

We are a SEBI registered investement advisor